HFrEF - for all adult patients, regardless of whether they have type 2 diabetes (FDA May 2020) reduces the risk of CV death and hospitalization for adults with heart failure and reduced ejection fraction (NYHA class II-IV)
This natural progression means patience is essentialrapid initial losses often slow, which is normal and healthy biology, not a sign of treatment failure
Ozempic (semaglutide) is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, making adequate protein intake challenging for many patients
This could open up many avenues for accessibility to this med
By combining your medication with a balanced diet, regular exercise, and a nutrition plan rich in protein and vitamins, you can protect your muscle mass and keep your energy levels high
Augustine Medical Weight Loss Consultation Required